Introduction: What they say:
A study from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA has reported that “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.”
This study was published in the June 25, 2014 Nature [I.F >42] by Prof. Wan Y, Krzeszinski and others from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
What we say:
On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Natural product therapy for Bone disorders: Chebulagic acid (CHA), isolated from Terminalia chebula, inhibits the expression of Tgif2 and suppresses osteoporosis and bone metastasis via up-regulation of its target gene.
From Research findings to Therapeutic utility:
Chebulagic acid (CHA), by up-regulating its target gene, it may suppress the expression of Tgif2 (figs. 1-2). Thereby, it may inhibit the progression of Osteoporosis and bone metastasis.
Figure 1. Terminalia chebula. Chebulagic acid, isolated from Terminalia chebula, inhibits the progression of Osteoporosis and bone metastasis via down regulation of Tgif2
Figure 2. Chebulagic acid. Image credit: Wikipedia
[easy_payment currency=”USD”]
Thus, pharmacological formulations encompassing “Chebulagic acid (CHA) or its analogues or CHA plus any of the known compounds that are in use to treat osteoporosis” can be used to inhibit osteoporosis and bone metastasis.
Details of the research findings:
Undisclosed information: How Chebulagic acid suppresses the expression of Tgif2
Amount: $50#
Idea Formulated (with experimental evidence) by: Dr L Boominathan PhD
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
#Research cooperation
For purchase & payment details, you may reach us at admin@genomediscovery.org
Reference:
Citation: Boominathan, L., Natural product therapy for Bone disorders: Chebulagic acid (CHA), isolated from Terminalia chebula, inhibits the expression of Tgif2 and suppresses osteoporosis and bone metastasis via up-regulation of its target gene, 3/December/2016, 7.49 pm., Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org